114 related articles for article (PubMed ID: 19572414)
1. The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow.
Fiume L; Baglioni M; Busi C; Manerba M; Di Stefano G
Eur J Pharm Biopharm; 2009 Aug; 72(3):630-1. PubMed ID: 19572414
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
[TBL] [Abstract][Full Text] [Related]
3. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
[TBL] [Abstract][Full Text] [Related]
4. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
[TBL] [Abstract][Full Text] [Related]
5. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
[TBL] [Abstract][Full Text] [Related]
6. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L
Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276
[TBL] [Abstract][Full Text] [Related]
7. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.
Elsadek B; Mansour A; Saleem T; Warnecke A; Kratz F
Dig Liver Dis; 2017 Feb; 49(2):213-222. PubMed ID: 27825923
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
[TBL] [Abstract][Full Text] [Related]
10. Lactosaminated human albumin, a hepatotropic carrier of drugs.
Fiume L; Di Stefano G
Eur J Pharm Sci; 2010 Jul; 40(4):253-62. PubMed ID: 20403430
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging.
Di Stefano G; Fiume L; Baglioni M; Bolondi L; Chieco P; Kratz F; Pariali M; Rubini G
Dig Liver Dis; 2008 Apr; 40(4):278-84. PubMed ID: 18054847
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis.
Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M
Dig Liver Dis; 2006 Jun; 38(6):404-8. PubMed ID: 16595196
[TBL] [Abstract][Full Text] [Related]
13. Imatinib for hepatocellular cancer--focus on pharmacokinetic/pharmacodynamic modelling and liver function.
Treiber G; Wex T; Schleyer E; Troeger U; Hosius C; Malfertheiner P
Cancer Lett; 2008 Feb; 260(1-2):146-54. PubMed ID: 18083304
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier.
Di Stefano G; Kratz F; Lanza M; Fiume L
Dig Liver Dis; 2003 Jun; 35(6):428-33. PubMed ID: 12868680
[TBL] [Abstract][Full Text] [Related]
15. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate.
Di Stefano G; Lanza M; Kratz F; Merina L; Fiume L
Eur J Pharm Sci; 2004 Dec; 23(4-5):393-7. PubMed ID: 15567293
[TBL] [Abstract][Full Text] [Related]
16. Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
Baglioni M; Fiume L; Bolondi L; Farina C; Kratz F; Di Stefano G
Dig Liver Dis; 2008 Dec; 40(12):963-4. PubMed ID: 18606580
[No Abstract] [Full Text] [Related]
17. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
[TBL] [Abstract][Full Text] [Related]
19. [Study on imatinib trough concentration, efficacy and their relation in chronic myelocytic leukemia].
Zhong JS; Meng FY; Xu D; Zhou HS; Dai M
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):177-82. PubMed ID: 22781602
[TBL] [Abstract][Full Text] [Related]
20. Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.
Vlahovic G; Ponce AM; Rabbani Z; Salahuddin FK; Zgonjanin L; Spasojevic I; Vujaskovic Z; Dewhirst MW
Br J Cancer; 2007 Sep; 97(6):735-40. PubMed ID: 17712313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
